BIOMAT Database Logo BIOMAT Database Logo

Small HIV-1-Tat peptides inhibit HIV replication in cultured T-cells. 2003

Marianne Löhr, and Karen V Kibler, and Ian Zachary, and Kuan-Teh Jeang, and David L Selwood
The Wolfson Institute for Biomedical Research, University College London, The Cruciform Building, Gower Street, London WC1E 6BT, UK.

Full-length soluble HIV-1 Tat protein has been shown to bind the CXCR4 receptor. Occupancy of CXCR4 by Tat inhibits infection of cells by T-tropic HIV-1. To understand if fragments of the Tat protein may have similar anti-HIV activity, we synthesized Tat peptides and tested their activity in tissue culture. Here, we report a sequence-specific contribution of Tat residues 31-35 to anti-HIV-1 activity.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015696 Gene Products, tat Trans-acting transcription factors produced by retroviruses such as HIV. They are nuclear proteins whose expression is required for viral replication. The tat protein stimulates LONG TERMINAL REPEAT-driven RNA synthesis for both viral regulatory and viral structural proteins. Tat stands for trans-activation of transcription. tat Gene Products,tat Protein,Gene Product, tat,tat Gene Product

Related Publications

Marianne Löhr, and Karen V Kibler, and Ian Zachary, and Kuan-Teh Jeang, and David L Selwood
Inhibition of HIV-1 virus replication using small soluble Tat peptides.
February 2006, Virology,
Marianne Löhr, and Karen V Kibler, and Ian Zachary, and Kuan-Teh Jeang, and David L Selwood
Insulin-like growth factor 1 and insulin inhibit HIV type 1 replication in cultured cells.
May 1995, AIDS research and human retroviruses,
Marianne Löhr, and Karen V Kibler, and Ian Zachary, and Kuan-Teh Jeang, and David L Selwood
Helper T-cell recognition of HIV-1 Tat synthetic peptides.
August 1993, Journal of acquired immune deficiency syndromes,
Marianne Löhr, and Karen V Kibler, and Ian Zachary, and Kuan-Teh Jeang, and David L Selwood
Tat peptides inhibit neprilysin.
June 2006, Journal of neurovirology,
Marianne Löhr, and Karen V Kibler, and Ian Zachary, and Kuan-Teh Jeang, and David L Selwood
Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replication.
June 2012, Journal of virology,
Marianne Löhr, and Karen V Kibler, and Ian Zachary, and Kuan-Teh Jeang, and David L Selwood
Metallo supramolecular cylinders inhibit HIV-1 TAR-TAT complex formation and viral replication in cellulo.
September 2018, Scientific reports,
Marianne Löhr, and Karen V Kibler, and Ian Zachary, and Kuan-Teh Jeang, and David L Selwood
Human immunodeficiency virus-1 tat- and tat/nef-defective genomes containing HIV-regulated diphtheria toxin A chain gene inhibit HIV replication.
October 2002, Croatian medical journal,
Marianne Löhr, and Karen V Kibler, and Ian Zachary, and Kuan-Teh Jeang, and David L Selwood
HEXIM1-Tat chimera inhibits HIV-1 replication.
November 2018, PLoS pathogens,
Marianne Löhr, and Karen V Kibler, and Ian Zachary, and Kuan-Teh Jeang, and David L Selwood
Soluble HIV-1 gp120 enhances HIV-1 replication in non-dividing CD4+ T cells, mediated via cell signaling and Tat cofactor overexpression.
June 2005, AIDS (London, England),
Marianne Löhr, and Karen V Kibler, and Ian Zachary, and Kuan-Teh Jeang, and David L Selwood
[HIV-TAT mediated transduction of targeted ribonuclease can inhibit HBV replication].
June 2004, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology,
Copied contents to your clipboard!